David Stout joins Shire's board
This article was originally published in Scrip
Executive Summary
Shire Pharmaceuticals has appointed Dr David Stout non-executive director on its board. Dr Stout was previously president of pharmaceutical operations at GlaxoSmithKline, where he was also responsible for global manufacturing and global biologics. Before that, he was president of GSK's US pharmaceuticals business. He is also a director of Allos Therapeutics, Jabil Circuit and Airgas.